Complete Genomics, the California sequencing company, gained a partial victory in Illumina’s patent suit against the company. The judge rejected Claim 1 of the suit, ruling that prior art shows Illumina’s technology was not novel. In September, BGI, the giant sequencing company headquartered in Shenzhen, announced it would buy Complete Genomics for $127 million. More details.... Stock Symbols: (NSDQ: GNOM) (NSDQ: ILMN) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});